[1] 李建中,吴爱勤,吴彩云.肿瘤患者的心理社会因素与免疫功能的测定.中国心理卫生杂志,2002,16(6):386-389
[2] Ikeda H,Chamoto K,Tsuji T,et al.The critical role of type-1 innate and acquired immunity in tumor immunotherapy.Cancer Sci,2004,95(9):697-703
[3] Oizumi S,Strbo N,Pahwa S,et al.Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxie T lymphocytes.Immtmol,2007,179(4):2310-2317
[4] 殷缨,张盈华,张利朝,等.恶性肿瘤患者T细胞亚群与红细胞免疫功能的变化及其相关性分析.实用癌症杂志,2001,16(2):171-173
[5] 蒋红飞.癌症患者的T淋巴细胞亚群免疫功能的研究.国际检验医学杂志,2006,27(7):660-661
[6] 董增义.恶性肿瘤病人手术及化疗前后T淋巴细胞亚群的变化.齐鲁医学杂志,2003,18(2):131-132
[7] Karin L,Bernhard D,Monkia H,et al.The effectiveness of relaxation training in reducing treatment related symptoms and improving emotional adjustment in acute non-surgical cancer treatment:A meta-analytieal review.Psyeho-oncology,2001,10(6):490-502
[8] 贾玫,陈信义.肿瘤心理神经免疫学研究进展.医学研究通讯,2005,(34)10:63-65
[9] Skírnisdóttir I,Lindborg K,Sorbe B,et al.Adjuvant chemotherapy with carboplatin and taxane compared with single drug carboplatin in early stage epithelial ovarian carcinoma.Oncol Rep,2007,18(5):1249-1256
|